Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-000721
Filing Date
2017-07-21
Accepted
2017-07-21 16:13:50
Documents
1
Period of Report
2017-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4850.html 4  
1 PRIMARY DOCUMENT doc4_4850.xml 4 6872
  Complete submission text file 0001638599-17-000721.txt   8366
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTRESS BIOTECH, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019
Business Address
Klein Dov (Reporting) CIK: 0001647971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 17976729